Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Clareo Health | Breast Cancer Clinical Trials in Cleveland | 437 Studies

Clinical Trials Breast CancerCleveland

Breast Cancer Clinical Trials in Cleveland

Find 437 clinical trials for breast cancer near Cleveland, Ohio. Connect with research centers in your area.

All Breast Cancer trials nationwide All trials in Cleveland

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 121-140 of 437 trials

Active not recruitingA Study of Trastuzumab Deruxtecan (T-DXd) Versus Trastuzumab Emtansine (T-DM1) in High-risk HER2-positive Participants With Residual Invasive Breast Cancer Following Neoadjuvant Therapy (DESTINY-Breast05)Patients with HER2-positive primary breast cancer (BC) who do not achieve complete response after appropriate neoadjuvant therapy are at higher risk of disease recurrence.NCT04622319·Anaheim, California and 481 others

Breast Cancer Trials in Other Cities

New York Los Angeles Chicago Houston Phoenix Philadelphia

Data from ClinicalTrials.govTerms

CompletedPazopanib (VOTRIENT) Plus Paclitaxel (TAXOL), Pazopanib Plus Paclitaxel (TAXOL) Plus Carboplatin (PARAPLATIN), and Pazopanib Plus Paclitaxel (TAXOL) Plus Lapatinib (TYKERB)Pazopanib will be given with TAXOL in one part, in another part pazopanib will be given with TAXOL and PARAPLATIN, and in a third part pazopanib will be given with TAXOL and…NCT00388076·New Brunswick, New Jersey and 2 others

CompletedAvelumab in Metastatic or Locally Advanced Solid Tumors (JAVELIN Solid Tumor)This is a Phase 1, open-label, dose-escalation trial of avelumab \[antibody targeting programmed death ligand 1 (anti PD-L1)\] with consecutive parallel group expansion in…NCT01772004·Goodyear, Arizona and 73 others

CompletedInvestigation of Novel Surgical Imaging for Tumor ExcisionThis is a multi-center, two-arm randomized, blinded pivotal study to demonstrate the safety and efficacy of the LUM Imaging System (LUM015 imaging agent in conjunction with the…NCT03686215·Mobile, Alabama and 13 others

Active not recruitingGedatolisib Plus Fulvestrant With or Without Palbociclib vs Standard-of-Care for the Treatment of Patients With Advanced or Metastatic HR+/HER2- Breast Cancer (VIKTORIA-1)This is a Phase 3, open-label, randomized, clinical trial evaluating the efficacy and safety of gedatolisib plus fulvestrant with or without palbociclib for the treatment of…NCT05501886·Birmingham, Alabama and 234 others

CompletedRollover Study Of Lapatinib In Cancer PatientsThe EGF19060 study is a rollover study to evaluate the long term safety of lapatinib and to provide lapatinib to patients who had a positive response in previous lapatinib studies…NCT00169533·Indianapolis, Indiana and 11 others

CompletedA Study of Neoadjuvant Nivolumab + Palbociclib + Anastrozole in Post-Menopausal Women and Men With Primary Breast CancerA randomized multi-arm study evaluating the safety and efficacy of palbociclib and anastrozole with or without nivolumab in participants with ER+/HER2- breast cancerNCT04075604·Whittier, California and 35 others

CompletedInterferon Alfa in Treating Patients With Stage IV Solid Tumors, Lymphoma, or MyelomaRATIONALE: Interferon alfa may interfere with the growth of cancer cells and slow the growth of cancer.NCT00276536·Cleveland, Ohio

TerminatedA Phase 1 Study of 68Ga-R11228 and 177Lu-R11228 in Breast CancerA phase 1 study of 68Ga-R11228 and 177Lu-R11228 in breast cancer.NCT07121244·Indianapolis, Indiana and 6 others

UnknownInvestigating the Use of Drains and (Internal) Quilting Sutures on Seroma Formation Following MastectomySeroma formation is a common complication following breast and axillary surgery for breast cancer.NCT02668263·Stockton-on-Tees, Cleveland

Active not recruitingRegional Radiotherapy in Biomarker Low-Risk Node Positive and T3N0 Breast CancerThe purpose of this study is to compare the effects on low risk breast cancer receiving usual care that includes regional radiation therapy, with receiving no regional radiation…NCT03488693·Fairbanks, Alaska and 484 others

CompletedWhole Brain Radiation Therapy With Oxygen, With or Without RSR13, in Women With Brain Metastases From Breast CancerRSR13 (efaproxiral) is a radiation sensitizer that has shown positive results in a Phase 3, randomized clinical trial of patients with brain metastases.NCT00083304·Phoenix, Arizona and 93 others

RecruitingA Study With NKT5097 for Adults With Advanced/Metastatic Solid TumorsThe goal of this open-label dose escalation and expansion study is to evaluate the safety and tolerability of NKT5097 in adults with advanced/metastatic tumors (emphasis on breast…NCT07029399·Duarte, California and 17 others

CompletedStudy of Chemotherapy in Combination With IDO Inhibitor in Metastatic Breast CancerThe purpose of this study is to compare the effects, good and/or bad, of standard of care therapy (docetaxel or paclitaxel) with or without the addition of 1-Methyl-D-tryptophan…NCT01792050·Gainesville, Florida and 39 others

Active not recruitingThe Hurria Older PatiEnts (HOPE) With Breast Cancer StudyThe goal of this study is to develop a "bedside to bench" model of clinical and biological predictors for toxicity to adjuvant and neoadjuvant chemotherapy in older adults with…NCT01472094·Duarte, California and 16 others

CompletedBreast Cancer Trial of RPR109881 Versus Capecitabine in Male or Female Patients With Advanced Breast CancerThe purpose of this clinical trial is to determine if RPR109881 is a better treatment than capecitabine (Xeloda) for advanced breast cancer in patients that no longer benefit from…NCT00081796·Birmingham, Alabama and 186 others

RecruitingEvaluation of the Safety and Efficacy of Treatment w/High Dose Melphalan Given Directly Into the Liver Followed by Treatment w/Approved Cancer Treatment or Approved Cancer Treatment Alone in Patients w/ Metastatic Breast Cancer w/Liver Dominant DiseaseThe goal of this clinical trial is to learn if using a liver-directed therapy with high dose chemotherapy followed by approved cancer treatment to treat patients with breast…NCT06875128·Tampa, Florida and 4 others

TerminatedA Phase III Trial of Niraparib Versus Physician's Choice in HER2 Negative, Germline BRCA Mutation-positive Breast Cancer PatientsThe purpose of this study is to compare progression-free survival (PFS) in patients with advanced/metastatic breast cancer who have a BRCA mutation when treated with niraparib as…NCT01905592·Tucson, Arizona and 103 others

Active not recruitingDoxorubicin Hydrochloride, Cyclophosphamide, and Paclitaxel With or Without Bevacizumab in Treating Patients With Lymph Node-Positive or High-Risk, Lymph Node-Negative Breast CancerThis randomized phase III trial studies doxorubicin hydrochloride, cyclophosphamide, and paclitaxel to see how well they work with or without bevacizumab in treating patients with…NCT00433511·Anniston, Alabama and 841 others

Active not recruitingAn Adjuvant Endocrine-based Therapy Study of Camizestrant (AZD9833) in ER+/HER2- Early Breast Cancer (CAMBRIA-2)This is a Phase III open-label study to assess if camizestrant improves outcomes compared to standard adjuvant endocrine therapy for patients with ER+/HER2- early breast cancer…NCT05952557·Dothan, Alabama and 660 others

PreviousPage 7 of 22Next

Other Conditions in Cleveland

Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia Lymphoma